| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
99,244 |
82,604 |
$13.17M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,027 |
38,146 |
$5.34M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,952 |
1,702 |
$3.14M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14,244 |
12,451 |
$1.72M |
| 71045 |
Radiologic examination, chest; single view |
10,914 |
9,093 |
$1.41M |
| A0425 |
Ground mileage, per statute mile |
10,642 |
8,816 |
$963K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
9,230 |
8,148 |
$810K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,218 |
10,803 |
$752K |
| 99221 |
|
1,429 |
569 |
$735K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,452 |
3,726 |
$679K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
7,712 |
6,388 |
$622K |
| 71046 |
Radiologic examination, chest; 2 views |
6,020 |
5,071 |
$419K |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
193 |
165 |
$405K |
| 99218 |
|
700 |
332 |
$393K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
85,431 |
64,556 |
$336K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
1,084 |
989 |
$286K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,679 |
830 |
$233K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
59,151 |
46,325 |
$225K |
| A0436 |
Rotary wing air mileage, per statute mile |
193 |
165 |
$201K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,522 |
646 |
$161K |
| 97597 |
|
764 |
295 |
$85K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,084 |
1,770 |
$78K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
358 |
326 |
$73K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,966 |
2,475 |
$67K |
| 36415 |
Collection of venous blood by venipuncture |
43,580 |
33,417 |
$67K |
| 81001 |
|
33,599 |
28,280 |
$55K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
130 |
106 |
$48K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
430 |
411 |
$47K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,172 |
963 |
$45K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
73 |
27 |
$40K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
308 |
119 |
$35K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
398 |
319 |
$35K |
| 80076 |
|
9,059 |
6,372 |
$33K |
| 80053 |
Comprehensive metabolic panel |
4,372 |
2,610 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
423 |
403 |
$28K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
47 |
40 |
$27K |
| 70450 |
Computed tomography, head or brain; without contrast material |
322 |
254 |
$22K |
| 36591 |
|
4,087 |
1,446 |
$22K |
| 84484 |
|
2,906 |
2,316 |
$21K |
| 74230 |
|
229 |
191 |
$21K |
| 74018 |
|
86 |
81 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
864 |
722 |
$16K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,374 |
852 |
$16K |
| 92611 |
|
169 |
130 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
829 |
695 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
809 |
427 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
472 |
438 |
$13K |
| 95822 |
|
40 |
25 |
$12K |
| 81000 |
|
3,695 |
3,232 |
$12K |
| 95819 |
|
15 |
15 |
$11K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
228 |
106 |
$11K |
| 84703 |
|
2,742 |
2,374 |
$10K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,017 |
3,753 |
$10K |
| 83690 |
|
3,309 |
2,767 |
$10K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
97 |
81 |
$9K |
| 85045 |
|
2,551 |
1,933 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
152 |
110 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
116 |
57 |
$8K |
| 97605 |
|
78 |
12 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
352 |
335 |
$8K |
| 73630 |
|
236 |
157 |
$8K |
| 83735 |
|
2,632 |
1,118 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
223 |
209 |
$7K |
| G0378 |
Hospital observation service, per hour |
69 |
24 |
$6K |
| 31231 |
|
15 |
15 |
$5K |
| 36430 |
|
14 |
13 |
$5K |
| 82728 |
|
406 |
342 |
$5K |
| 97116 |
|
111 |
42 |
$4K |
| 73130 |
|
95 |
39 |
$4K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
13 |
12 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
80 |
51 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
17 |
16 |
$3K |
| 84100 |
|
1,457 |
515 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
150 |
128 |
$2K |
| 83020 |
|
193 |
157 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
93 |
68 |
$2K |
| 85027 |
|
558 |
317 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
29 |
28 |
$2K |
| 81025 |
|
251 |
224 |
$1K |
| 85660 |
|
156 |
101 |
$1K |
| 87210 |
|
296 |
243 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
189 |
175 |
$1K |
| 80069 |
|
181 |
132 |
$937.44 |
| 82077 |
|
70 |
52 |
$777.14 |
| 96367 |
|
28 |
12 |
$737.10 |
| 72040 |
|
14 |
13 |
$729.74 |
| 72100 |
|
13 |
12 |
$663.40 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
156 |
128 |
$369.69 |
| 82948 |
|
112 |
90 |
$359.82 |
| 87081 |
|
124 |
114 |
$317.09 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
16 |
13 |
$297.06 |
| 96376 |
|
213 |
67 |
$221.13 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,229 |
1,866 |
$214.73 |
| 82803 |
|
15 |
12 |
$209.96 |
| 85379 |
|
18 |
12 |
$163.87 |
| 83605 |
|
13 |
12 |
$150.41 |
| 86850 |
|
13 |
13 |
$127.01 |
| 83550 |
|
12 |
12 |
$104.88 |
| 84702 |
|
13 |
13 |
$92.20 |
| 83540 |
|
12 |
12 |
$77.64 |
| 86901 |
|
13 |
13 |
$38.87 |
| 86900 |
|
13 |
13 |
$38.87 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,551 |
2,944 |
$29.37 |
| 85007 |
|
13 |
12 |
$4.11 |
| J2704 |
Injection, propofol, 10 mg |
955 |
776 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,228 |
1,157 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
875 |
699 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
97 |
86 |
$0.00 |
| A0434 |
Specialty care transport (sct) |
929 |
797 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
402 |
318 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
49 |
42 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
48 |
41 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
15 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
39 |
38 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
52 |
35 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
14 |
12 |
$0.00 |
| 90715 |
|
104 |
87 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
398 |
335 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
675 |
572 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
210 |
64 |
$0.00 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
63 |
54 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
31 |
25 |
$0.00 |